Literature DB >> 20001500

Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer.

Kristoffer Derwinger1, Karl Kodeda, Elinor Bexe-Lindskog, Helena Taflin.   

Abstract

AIM: The tumour differentiation grade has been shown by numerous multivariate analyses to be a stage-independent prognostic factor in colorectal cancer. The aim of this study was to explore the importance of differentiation grading for the staging of colorectal cancer and how it relates to the components of the TNM system.
MATERIAL AND METHODS: The study was a retrospective single-centre analysis of all patients undergoing surgical resection for colorectal cancer during the period 2002-2007 (n = 1239). The clinical parameters and pathology data of overall stage, differentiation grade, local tumour (T)-stage and metastasis status (M-stage) were included as well as the lymph node count of both assessed and metastatic nodes. The differentiation grade was correlated with demography, overall stage and each component of the TNM staging system. The correlation between differentiation grade and N-stage was also explored for the separate T-stages.
RESULTS: The tumour differentiation grade correlated significantly with the overall TNM stage (p < 0.0001). The grade significantly correlated with the T-stage and the risk of having lymph node metastasis (p < 0.0001). A high grade was associated with a higher positive lymph node count in stage III disease (p < 0.0002). For the T-stages, the risk of node metastasis was significantly linked to the tumour grade. A low grade (G1) T2 had a 17% risk of lymph node metastasis compared to a 44% risk for a high grade (G4) T2.
CONCLUSION: Tumour differentiation is an important prognostic factor. It correlates significantly with the overall stage of the TNM system and also to each of its components. The risk of having lymph node metastasis for each T-stage also correlates with the tumour grade. The findings can be of importance in postoperative risk assessment or when considering local resection procedures like TEM.

Entities:  

Mesh:

Year:  2010        PMID: 20001500     DOI: 10.3109/02841860903334411

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  29 in total

1.  Serum GROβ: a potential tumor-associated biomarker for colorectal cancer.

Authors:  Zhaoxu Zheng; Min Zheng; Jianjun Bi; Qiang Feng; Zhigang Yue; Yanqiu Zhou; Wanning Hu; Haizeng Zhang; Hongjun Gao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma.

Authors:  Qiao-Mei Dong; Jin-Qiang Zhang; Qian Li; Jacqueline C Bracher; Denver T Hendricks; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

3.  Population-based screening improves histopathological prognostic factors in colorectal cancer.

Authors:  Mónica Mengual-Ballester; Enrique Pellicer-Franco; Graciela Valero-Navarro; Victoriano Soria-Aledo; José Andrés García-Marín; José Luis Aguayo-Albasini
Journal:  Int J Colorectal Dis       Date:  2017-11-14       Impact factor: 2.571

4.  Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis.

Authors:  Lennard Y W Lee; Connor Woolley; Thomas Starkey; Sujata Biswas; Tia Mirshahi; Chiara Bardella; Stefania Segditsas; Shazia Irshad; Ian Tomlinson
Journal:  Clin Cancer Res       Date:  2018-10-15       Impact factor: 12.531

5.  ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-β axis in colorectal cancer.

Authors:  Jiayang Liu; Zhao Huang; Hai-Ning Chen; Siyuan Qin; Yan Chen; Jingwen Jiang; Zhe Zhang; Maochao Luo; Qin Ye; Na Xie; Zong-Guang Zhou; Yuquan Wei; Ke Xie; Canhua Huang
Journal:  Oncogene       Date:  2021-04-19       Impact factor: 9.867

6.  The clinical features, management, and survival of elderly patients with colorectal cancer.

Authors:  Lei Shen; Ke Meng; Yifei Wang; Xiangli Yu; Ping Wang; Xiaomei Zhang
Journal:  J Gastrointest Oncol       Date:  2021-02

7.  Colon Cancer Grading Using Infrared Spectroscopic Imaging-Based Deep Learning.

Authors:  Saumya Tiwari; Kianoush Falahkheirkhah; Georgina Cheng; Rohit Bhargava
Journal:  Appl Spectrosc       Date:  2022-03-25       Impact factor: 3.588

8.  Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer.

Authors:  Elinor B Lindskog; Yvonne Wettergren; Elisabeth Odin; Bengt Gustavsson; Kristoffer Derwinger
Journal:  Clin Med Insights Oncol       Date:  2012-10-15

9.  A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.

Authors:  Elinor Bexe Lindskog; Katrín Ásta Gunnarsdóttir; Kristoffer Derwinger; Yvonne Wettergren; Bengt Glimelius; Karl Kodeda
Journal:  BMC Cancer       Date:  2014-12-13       Impact factor: 4.430

10.  Extramural vascular invasion detected by contrast-enhanced multiple-row detectors computed tomography (ceMDCT) as a predictor of synchronous metastases in colon cancer.

Authors:  Su-Xing Yang; Xun Yao; Xing-He Song; Yan-Cheng Cui; Ying-Jiang Ye; Yi Wang
Journal:  Oncotarget       Date:  2017-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.